Company news

Kiniksa Pharmaceuticals International, plc news in 2024

Kiniksa Pharmaceuticals International, plc's news releases, calls and decks from 2024, newest first.

View company

Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference

November 25, 2024

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference

November 11, 2024

Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

October 28, 2024

Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis

October 27, 2024

Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024

October 21, 2024

NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis

September 30, 2024

Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference

August 27, 2024

Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution

July 22, 2024

Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024

July 15, 2024

Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease

July 8, 2024

Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis

June 23, 2024

Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative

June 16, 2024

Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

June 3, 2024

Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference

May 6, 2024

Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution

April 22, 2024

Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024

April 15, 2024

Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart

April 1, 2024

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution

February 27, 2024

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

February 20, 2024

Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference

January 1, 2024

Calls in 2024

Decks in 2024